Thirdhand smoke is a new frontier, and UC's Tobacco-Related Disease Research Program has assembled a consortium of investigators to study the health risks caused by the remnants of cigarette smoke.
An ambitious project, teaming Kaiser Permanente and UCSF researchers, takes aim at genetic links to disease.
A multicampus center connects researchers and people in the community to address poverty, employment, health, the environment and other California issues.
Graduate students are at the heart of UC research. And many package their expertise, creativity and compassion to tackle and solve key problems in California and beyond.
Based on research by UCSF and UC San Diego, the FDA has identified an arthritis treatment as an 'orphan drug.' It paves the way for a new drug to attack tropical parasites that disable and kill millions of people worldwide.
Dollars donated by California tax filers support innovative research to fight breast cancer and tobacco-related diseases.
For more than a decade, stem cell science has raised hopes of cures for a host of diseases and illnesses. Now, the research pace has picked up with lab discoveries moving to tests of therapies for patients.
UCSF bioengineer Tejal Desai builds medical implants, with parts as tiny as human cells, that may be used to treat diabetes, kidney failure and other diseases.
Doctors at a UCSF Fresno program don't just provide emergency care to those who become sick or injured in the backcountry. They research lifesaving techniques and have become leading specialists in wilderness medicine.
They delivered a message to legislators: graduate student research is central not only to the future of UC, but to that of the state and the nation as well.
Five UC graduate students and postdoctoral researchers were among innovators named 'Rising Stars of Science: The Forbes 30 under 30.'
For many women, a diagnosis of ovarian cancer is a death sentence. More than 14,000 women die of it each year. With symptoms that mimic other ailments, it often is diagnosed at a late stage. The five-year survival rate is just 31 percent; when the cancer becomes resistant to traditional chemotherapy, newer drugs have held it at bay for a few months at best.